Ovarian cancers associate with advanced histologic grade and disease stage (BRCA1 and BRCA2 mutation groups, respectively), similarly to the results reported by Lakhani et al. (2004) [50]. This evidence concerns the gene BRCA2 and ovarian carcinoma.